Analysis of tumor biopsy tissues from a woman with stage II breast cancer who underwent three cycles of neoadjuvant chemotherapy with doxorubicin, docetaxel, and cyclophosphamide (TAC) revealed a 3 bp somatic insertion in the p53 gene (c.720_721insAGT, p.240dupS). The gene discussed is TP53; the disease is breast cancer.